• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Treatment of superficial bladder cancer.浅表性膀胱癌的治疗
Can Med Assoc J. 1980 May 24;122(10):1133-8.
2
Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.pTa/pT1期膀胱癌患者局部复发的危险因素。
Scand J Urol Nephrol. 2008;42(5):417-21. doi: 10.1080/00365590802016302.
3
The management of superficial bladder cancer.浅表性膀胱癌的管理
Nat Clin Pract Urol. 2007 May;4(5):254-60. doi: 10.1038/ncpuro0784.
4
The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?卡介苗治疗非肌层浸润性膀胱癌后复发的同步放化疗结果:是否总是需要立即进行膀胱切除术?
BJU Int. 2009 Jul;104(2):179-83. doi: 10.1111/j.1464-410X.2008.08299.x. Epub 2008 Dec 23.
5
Current concepts in the management of superficial bladder cancer.浅表性膀胱癌治疗的当前概念
Arch Esp Urol. 1990;43 Suppl 2:115-21.
6
Should bladder biopsies be performed routinely after bacillus Calmette-Guérin treatment for high-risk superficial transitional cell cancer of the bladder?
Eur Urol. 2006 Sep;50(3):516-20; discussion 520. doi: 10.1016/j.eururo.2006.03.022. Epub 2006 Mar 31.
7
Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.光动力经尿道膀胱肿瘤切除术能否改善初发T1期高级别膀胱癌的治疗效果?一项随机研究的长期随访
BJU Int. 2008 Mar;101(5):566-9. doi: 10.1111/j.1464-410X.2007.07314.x. Epub 2007 Nov 5.
8
Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.尿白细胞介素-8和18可预测浅表性膀胱癌对卡介苗膀胱内灌注治疗的反应。
J Urol. 2000 Dec;164(6):2129-33.
9
The role of surgery in the multimodality treatment of bladder cancer.手术在膀胱癌多模式治疗中的作用。
Cancer Surv. 1998;31:129-47.
10
Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.高危浅表性膀胱癌的再次经尿道切除术可改善对卡介苗治疗的初始反应。
J Urol. 2005 Dec;174(6):2134-7. doi: 10.1097/01.ju.0000181799.81119.fc.

引用本文的文献

1
Evaluation of local, regional and abscopal effects of Boron Neutron Capture Therapy (BNCT) combined with immunotherapy in an ectopic colon cancer model.硼中子俘获治疗(BNCT)联合免疫疗法对异位结肠癌模型的局部、区域和远隔效应的评价。
Br J Radiol. 2021 Dec;94(1128):20210593. doi: 10.1259/bjr.20210593. Epub 2021 Sep 14.
2
A sex-linked SNP mutation in amhr2 is responsible for male differentiation in obscure puffer (Takifugu obscurus).一个位于 amhr2 的性连锁 SNP 突变导致了暗纹东方鲀(Takifugu obscurus)的雄性分化。
Mol Biol Rep. 2021 Aug;48(8):6035-6046. doi: 10.1007/s11033-021-06606-4. Epub 2021 Aug 3.
3
Modulatory effect of mycobacterium cell wall extract (Regressin) on lymphocyte blastogenic activity and macrophage cytokine gene transcription in swine.分枝杆菌细胞壁提取物(Regressin)对猪淋巴细胞增殖活性及巨噬细胞细胞因子基因转录的调节作用
Clin Diagn Lab Immunol. 1997 May;4(3):314-20. doi: 10.1128/cdli.4.3.314-320.1997.
4
Current diagnostic and therapeutic methods in the treatment of vesical tumours.
Int Urol Nephrol. 1988;20(6):597-609. doi: 10.1007/BF02549492.

本文引用的文献

1
THE RESULTS OF USING RADIOACTIVE GOLD GRAINS IN THE TREATMENT OF BLADDER GROWTHS.使用放射性金颗粒治疗膀胱肿瘤的结果。
Br J Urol. 1964 Dec;36:541-8. doi: 10.1111/j.1464-410x.1964.tb09545.x.
2
Thiotepa in the treatment of tumours of the bladder.
Lancet. 1961 Sep 16;2(7203):615-8. doi: 10.1016/s0140-6736(61)90304-x.
3
Primary adenocarcinoma of bladder.
Urology. 1980 Feb;15(2):119-22. doi: 10.1016/0090-4295(80)90400-8.
4
Extracutaneous delayed hypersensitivity, particularly in the guinea-pig bladder.皮肤外迟发型超敏反应,尤其是在豚鼠膀胱中。
Immunology. 1966 Feb;10(2):127-36.
5
Results of the mucosal denudation for bladder tumors: an interim report.膀胱肿瘤黏膜剥脱术的结果:中期报告。
J Urol. 1968 Jun;99(6):725-7. doi: 10.1016/S0022-5347(17)62779-4.
6
The origin of regenerative bladder mucosa after partial mucosal stripping.部分黏膜剥脱后再生膀胱黏膜的起源
Invest Urol. 1971 Mar;8(5):481-7.
7
Mucosal denudation (stripping) for bladder papillomatosis.膀胱乳头瘤病的黏膜剥脱(剥离)术。
Scand J Urol Nephrol. 1969;3(3):204-7. doi: 10.3109/00365596909135406.
8
Intracavitary radiation in the treatment of bladder tumors.腔内放射治疗膀胱肿瘤
J Urol. 1972 Apr;107(4):603-6. doi: 10.1016/s0022-5347(17)61089-9.
9
Intracavitary chemotherapy for multiple non-invasive bladder tumours.
Br J Urol. 1971 Apr;43(2):181-4. doi: 10.1111/j.1464-410x.1971.tb12023.x.
10
Instillation of thio-tepa (Tifosyl) in vesical papillomatosis.硫代磷酸三乙酯(Tifosyl)膀胱灌注治疗膀胱乳头状瘤病。
Acta Radiol Ther Phys Biol. 1970 Oct;9(5):395-400. doi: 10.3109/02841867009129116.

浅表性膀胱癌的治疗

Treatment of superficial bladder cancer.

作者信息

Morales A

出版信息

Can Med Assoc J. 1980 May 24;122(10):1133-8.

PMID:6770987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1801981/
Abstract

Most patients with bladder cancer initially present with localized, potentially curable tumours. Endoscopic surgery offers the best opportunity to eliminate these early lesions, but the rate of tumour recurrence after adequate resection is high (around 70%). Conventional methods of treatment have a place in the management of early bladder neoplasms, but their success rate is still unsatisfactory and they frequently fail to decrease the risk of recurrence. New drugs and more effective forms of administration have enhanced the use of chemotherapeutic agents. Fundamentally different approaches, such as specific immunotherapy, the use of laser energy and photodynamic therapy, are emerging as valuable approaches in the treatment of superficial bladder cancer and the prevention of recurrence. Randomized trials to assess their value and a concerted multidisciplinary effort with combined treatment give hope for effective control of early bladder cancer.

摘要

大多数膀胱癌患者最初表现为局限性、有可能治愈的肿瘤。内镜手术为消除这些早期病变提供了最佳机会,但充分切除后肿瘤复发率很高(约70%)。传统治疗方法在早期膀胱肿瘤的管理中占有一席之地,但其成功率仍不尽人意,且常常无法降低复发风险。新药和更有效的给药方式增加了化疗药物的使用。诸如特异性免疫疗法、激光能量的应用和光动力疗法等截然不同的方法,正成为治疗浅表性膀胱癌和预防复发的有价值方法。评估其价值的随机试验以及联合治疗的多学科协同努力为有效控制早期膀胱癌带来了希望。